Peter Maag - 05 Oct 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Executive Chair, Director
Signature
/s/ Peter Maag
Issuer symbol
CDNA
Transactions as of
05 Oct 2021
Net transactions value
-$465,074
Form type
4
Filing time
06 Oct 2021, 19:40:59 UTC
Previous filing
07 Sep 2021
Next filing
09 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $5,843 +926 +0.27% $6.31 342,682 05 Oct 2021 Direct F1
transaction CDNA Common Stock Options Exercise $45,618 +3,727 +1.1% $12.24 346,409 05 Oct 2021 Direct F1
transaction CDNA Common Stock Options Exercise $130,199 +5,347 +1.5% $24.35 351,756 05 Oct 2021 Direct F1
transaction CDNA Common Stock Sale $335,502 -5,225 -1.5% $64.21 346,531 05 Oct 2021 Direct F1, F2
transaction CDNA Common Stock Sale $234,587 -3,612 -1% $64.95 342,919 05 Oct 2021 Direct F1, F3
transaction CDNA Common Stock Sale $76,645 -1,163 -0.34% $65.90 341,756 05 Oct 2021 Direct F1, F4
holding CDNA Common Stock 1,000 05 Oct 2021 As UTMA custodian for minor child F5
holding CDNA Common Stock 1,000 05 Oct 2021 As UTMA custodian for minor child F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -926 -9.4% $0.000000 8,941 05 Oct 2021 Common Stock 926 $6.31 Direct F1, F6
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -3,727 -13% $0.000000 25,000 05 Oct 2021 Common Stock 3,727 $12.24 Direct F1, F7
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -5,347 -8.6% $0.000000 56,906 05 Oct 2021 Common Stock 5,347 $24.35 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.52 to $64.52, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.53, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.59 to $66.25, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F5 Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F6 1/4th of the shares subject to the option shall vest on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F7 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F8 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.